2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Weekly Paclitaxel: new trials by email Literature Review of Weekly Paclitaxel trials Research Report on Weekly Paclitaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) NovoTTF-100L(O), Paclitaxel - Ovarian Cancer | Phase 3 | Completed | NovoCure Ltd. | 540 | 2019-03-22 | 2024-03-29 |
| Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients Trabectedin, Pegylated Liposomal Doxorubicin, Topotecan - Ovarian Neoplasms | Phase 3 | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 242 | 2016-04-11 | 2021-08-25 |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · NovoCure Ltd. (1)
Italy (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Poland (1) · Spain (1) · Switzerland (1) · United States (1)
Domenica Lorusso, Prof. (1) · Ignace Vergote, MD (1)
PMID 10655437, PMID 11165136, PMID 11304695, PMID 11479630, PMID 16912194, PMID 21376569, PMID 21835933, PMID 23397080, PMID 23410977, PMID 38315944